Skip to main content
. 2017 Mar 13;9(4):696–703. doi: 10.1080/19420862.2017.1299848

Figure 5.

Figure 5.

Percent survival of IFNAR-/- mice administered MARV GP specific scFv-Fc antibodies. Each mouse was administered 100ug of scFv-Fc antibody treatment, irrelevant antibody (n=10), or PBS (n=10) on Days −1, 1, and 3. Mice were challenged with 1000 pfu MARV Ci67 on D0.